Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma

被引：11

作者：

da Silva, Priscilla Brito ^{[1
]}

Real, Juliana Monte ^{[2
,3
,4
]}

Pinto Ferreira, Ludmila Rodrigues ^{[5
]}

Esteves, Gustavo H. ^{[6
]}

Brito, Fabio do Nascimento ^{[1
]}

Baiocchi, Otavio C. G. ^{[1
,7
]}

机构：

[1] Univ Fed Sao Paulo, UNIFESP, Dept Oncol Clin & Expt, Sao Paulo, Brazil

[2] Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil

[3] Hosp Serv Publ Estadual Sao Paulo, IAMSPE, Sao Paulo, Brazil

[4] Hosp Santa Marcelina, Assoc TUCCA Criancas & Adolescentes Com Canc, Dept Oncol Pediat, Sao Paulo, Brazil

[5] Univ Fed Minas Gerais, ICB UFGM, Inst Ciencias Biol, Dept Morphol, Belo Horizonte, MG, Brazil

[6] Univ Estadual Paraiba, UEPB, Dept Estat, Campina Grande, Brazil

[7] HAOC, Hematol Div, Sao Paulo, Brazil

来源：

HEMATOLOGICAL ONCOLOGY | 2018年 / 36卷 / 04期

基金：

巴西圣保罗研究基金会;

关键词：

DEATH-LIGAND; 1; MICROENVIRONMENT; EXPRESSION;

D O I：

10.1002/hon.2542

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：709 / 712

页数：4

共 14 条

[1] Hodgkin Lymphoma: Diagnosis and Treatment [J].

Ansell, Stephen M. .

MAYO CLINIC PROCEEDINGS, 2015, 90 (11) :1574-1583

[2] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[3]

Armand P, 2015, 57 ASH ANN M DEC 5 8

[4] Current and future immunotherapeutic approaches in Hodgkin lymphoma [J].

Broeckelmann, Paul J. ;

Borchmann, Peter ;

Engert, Andreas .

LEUKEMIA & LYMPHOMA, 2016, 57 (09) :2014-2024

[5]

Chen R., 2017, HEMATOL ONCOL, V35, P67, DOI [10.1002/hon.2437_54, DOI 10.1002/hon.2437_54]

[6] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[7] High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome [J].

Hollander, Peter ;

Kamper, Peter ;

Smedby, Karin Ekstrom ;

Enblad, Gunilla ;

Ludvigsen, Maja ;

Mortensen, Julie ;

Amini, Rose-Marie ;

Hamilton-Dutoit, Stephen ;

d'Amore, Francesco ;

Molin, Daniel ;

Glimelius, Ingrid .

BLOOD ADVANCES, 2017, 1 (18) :1427-1439

[8] Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma [J].

Koh, Young Wha ;

Jeon, Yoon Kyung ;

Yoon, Dok Hyun ;

Suh, Cheolwon ;

Huh, Jooryung .

TUMOR BIOLOGY, 2016, 37 (06) :7507-7514

[9] Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy [J].

Liu, Qiqi ;

Hu, Pingping ;

Deng, Guodong ;

Zhang, Jingxin ;

Liang, Ning ;

Xie, Jian ;

Qiao, Lili ;

Luo, Hui ;

Zhang, Jiandong .

ONCOTARGETS AND THERAPY, 2017, 10 :2147-2154

[10] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma [J].

Paydas, Semra ;

Bagir, Emine ;

Seydaoglu, Gulsah ;

Ercolak, Vehbi ;

Ergin, Melek .

ANNALS OF HEMATOLOGY, 2015, 94 (09) :1545-1552

← 1 2 →